The costs and process of developing anti-cancer drugs has been an extreme challenge for decades. Today one company, AccutarBio, is harnessing the power of AI to accelerate drug discovery and reform the current “hit-to-lead” drug discovery scheme. The company recently received $15 million in funding (including money from Chinese AI/facial recognition company YITU) and is now partnering with Amgen.
AI for Pharma R&D – Creating Anti-cancer Drugs Faster, Reducing Process from Years to Days
June 27, 2018 by Leave a Comment
Surface Reconstruction Based on Neural Networks
May 8, 2018 by Leave a Comment
Surface reconstruction is an important trend in 3D scanning. The problem is to recreate surfaces from a given point cloud within the shortest possible time and with a given quality criteria. There is a set of different approaches for solving this problem, which includes Self-Organized Maps, Bayesian reconstruction and Poisson reconstruction. The purpose of this article highlight a paper, “Surface Reconstruction Based on Neural Networks” that analyzes and compares results obtained with the usage of two self-organizing map types.
Surface Reconstruction Based on Neural Networks
May 2, 2018 by Leave a Comment
Surface reconstruction is an important trend in 3D scanning. The problem is to recreate surfaces from a given point cloud within the shortest possible time and with a given quality criteria. There is a set of different approaches for solving this problem, which includes Self-Organized Maps, Bayesian reconstruction and Poisson reconstruction. The aim of the […]
